Author:
Öberg Kjell,Yaşar Serkan,Yalcin Suayib
Publisher
Springer International Publishing
Reference11 articles.
1. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE et al (2008) One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26(18):3063–3072
2. ENTS. (ENETS) European Neuroendocrine Tumor Society (ENETS) (2021) https://www.enets.org
3. Rindi G, de Herder WW, O'Toole D, Wiedenmann B (2006) Consensus guidelines for the management of patients with digestive neuroendocrine tumors: why such guidelines and how we went about it. Neuroendocrinology 84(3):155–157
4. Kulke MH, Anthony LB, Bushnell DL, de Herder WW, Goldsmith SJ, Klimstra DS et al (2010) NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas 39(6):735–752
5. NANTS (NANETS). North American Neuroendocrine Tumor Society (NANETS) (2021). https://nanets.net